ANIP.OQ - ANI Pharmaceuticals Inc
Guggenheim Securities LLC
ANIP: Strong Generic Sales Drives 4Q25 Beat, But Continued Cortrophin Uptake Keeps Us Bullish Into 2026; Reiterate Buy; 4Q25 Initial Diagnosis
公司
ANIP.OQ
日期
2026-02-27
分析师
Mr. Vamil K. Divan, MD
页数
5 页
获取研报PDF
将完整研报PDF发送到您的邮箱。
请求PDF
转换为音频
将研报转换为AI生成的音频摘要,随时随地收听。
生成音频
需要登录
请登录后购买研报或生成音频内容。
ANIP: Strong Generic Sales Drives 4Q25 Beat, But Continued Cortrophin Uptake Keeps Us Bullish Into 2026; Reiterate Buy; 4Q25 Initial Diagnosis - ANI Pharmaceuticals Inc (ANIP.OQ) | 研报说 MoneyTalk | 研报说